Ownership history in PROFUND ADVISORS LLC · 33 quarters on record
This page tracks every 13F SEC filing in which PROFUND ADVISORS LLC reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 6,767 | -1,334 | -16.5% | 0.02% | $562K | $83.11 |
| 2025 Q2 | REDUCED | 8,101 | -3,000 | -27.0% | 0.02% | $595K | $73.40 |
| 2025 Q1 | REDUCED | 11,101 | -157 | -1.4% | 0.06% | $1.3M | $114.22 |
| 2024 Q4 | REDUCED | 11,258 | -5,286 | -32.0% | 0.02% | $567K | $50.39 |
| 2024 Q3 | REDUCED | 16,544 | -777 | -4.5% | 0.03% | $766K | $46.28 |
| 2024 Q2 | REDUCED | 17,321 | -6,260 | -26.5% | 0.02% | $563K | $32.49 |
| 2024 Q1 | ADDED | 23,581 | +7,427 | +46.0% | 0.02% | $594K | $25.19 |
| 2023 Q4 | ADDED | 16,154 | +4,697 | +41.0% | 0.02% | $525K | $32.48 |
| 2023 Q3 | REDUCED | 11,457 | -2,792 | -19.6% | 0.02% | $312K | $27.25 |
| 2023 Q2 | REDUCED | 14,249 | -762 | -5.1% | 0.02% | $317K | $22.25 |
As of 2025 Q4 — sorted by position size